Centogene NV logo

Centogene NV

1
NAS:CNTG (Germany)   Ordinary Shares
$ 0.52 -0.015 (-2.83%) 11:09 PM EST
Market Cap:
$ 14.94M
Enterprise V:
$ 83.14M
Volume:
25.65K
Avg Vol (2M):
85.74K
Trade In:
Volume:
25.65K
Avg Vol (2M):
85.74K

Business Description

Centogene NV logo
Centogene NV
NAICS : 621512 SIC : 8099
ISIN : NL0014040206

Share Class Description:

CNTG: Ordinary Shares
Description
Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Its geographic regions are Europe, the Middle East, North America, and Latin America.
Name Current Vs Industry Vs History
Cash-To-Debt 0.23
Equity-to-Asset -0.33
Debt-to-Equity -3.18
Debt-to-EBITDA N/A
N/A
N/A
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.37
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 64.52
9-Day RSI 71.82
14-Day RSI 70.11
6-1 Month Momentum % -67.58
12-1 Month Momentum % -70.21

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.02
Quick Ratio 0.96
Cash Ratio 0.42

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.5
Shareholder Yield % -159.48
Name Current Vs Industry Vs History
FCF Margin % -70.11

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio N/A
N/A
N/A
PE Ratio without NRI N/A
N/A
N/A
PS Ratio 0.27
EV-to-EBIT -2.82
EV-to-EBITDA -3.92
EV-to-Revenue 1.57
EV-to-Forward-Revenue 1.32
EV-to-FCF -2.24
Earnings Yield (Greenblatt) % -35.46
FCF Yield % -248.48

Financials (Next Earnings Date:2024-09-06 Est.)

CNTG's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CNTG

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Centogene NV Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 52.929
EPS (TTM) ($) 0
Beta 0.25
Volatility % 79.66
14-Day RSI 70.11
14-Day ATR ($) 0.038277
20-Day SMA ($) 0.446465
12-1 Month Momentum % -70.21
52-Week Range ($) 0.34 - 1.53
Shares Outstanding (Mil) 29

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Centogene NV Filings

Filing Date Document Date Form
No Filing Data

Centogene NV Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Centogene NV Frequently Asked Questions

What is Centogene NV(CNTG)'s stock price today?
The current price of CNTG is $0.52. The 52 week high of CNTG is $1.53 and 52 week low is $0.34.
When is next earnings date of Centogene NV(CNTG)?
The next earnings date of Centogene NV(CNTG) is 2024-09-06 Est..
Does Centogene NV(CNTG) pay dividends? If so, how much?
Centogene NV(CNTG) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1